期刊论文详细信息
Proceedings of Singapore Healthcare | |
Non-Alcoholic Fatty Liver Disease: | |
Hui-HuiTan1  | |
关键词: cirrhosis; fibroscan; metabolic syndrome; steatosis; steatohepatitis; | |
DOI : 10.1177/201010581001900106 | |
学科分类:医学(综合) | |
来源: Sage Journals | |
【 摘 要 】
Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic steatosis to non-alcoholic steatohepatitis with inflammation (NASH) and liver cirrhosis. NAFLD is now recognised as the hepatic manifestation of the metabolic syndrome. Simple steatosis is benign, whereas NASH can progress to cirrhosis with its resultant complications. Liver biopsy remains the gold standard in the diagnosis of NAFLD/NASH. Lifestyle and dietary modifications to achieve sustained weight loss is the cornerstone of NAFLD/NASH treatment.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201904021729295ZK.pdf | 139KB | download |